Results 201 to 210 of about 120,110 (313)

Transitional Cell Carcinoma

, 2020
openaire   +2 more sources

Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma. [PDF]

J Cardiothorac Surg
Kanzaki R, Nagoya A, Taniguchi S, Ishida H, Kimura K, Fukui E, Kimura T, Kanou T, Ose N, Funaki S, Minami M, Morii E, Shintani Y.   +12 more
europepmc   +1 more source

Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer. [PDF]

Ann Med, 2021
Yan X, Chen M, Xiao C, Fu J, Sun X, Hu Z, Zhou H.   +6 more
europepmc   +1 more source

Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen, Yuying Zhang, Heyu Zhang, Jinming Zhang, Ningning Wang, Xintong Guo, Yicong Liu, Yue Liu, Xiangsong Zhang, Ziyi Chen, Guanzhong Ni   +10 more
wiley   +1 more source

Expression of proto-oncogene c-Myc in patients with urinary bladder transitional cell carcinoma. [PDF]

Curr Urol, 2021
Fragkoulis C, Ntoumas G, Glykas I, Papadopoulos G, Stathouros G, Kostopoulou A, Choreftaki T, Ntoumas K.   +7 more
europepmc   +1 more source

[Sunitinib suppresses migration of ovarian cancer cells through negative modulation of TGF-β-mediated epithelial-mesenchymal transition]. [PDF]

, 2015
Zibo Chen, Linlin Chang, Tianyi Zhou, Dandan Wang, Ying Chen, Ping-ge Zhao, Hong Zhu   +6 more
openalex   +1 more source

An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma

, 2021
Youpeng Zhang, Yongbiao Cheng, Sen Li, Ning Zhao, Zhaohui Zhu   +4 more
openalex   +1 more source

Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment

Arthritis Care &Research, EarlyView.
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava, Catriona A. Wagner, Carla J. Guthridge, Susan Macwana, Wade DeJager, Melissa E. Munroe, Peter Izmirly, H. Michael Belmont, Betty Diamond, Anne Davidson, Paul J. Utz, Michael H. Weisman, Philip M. Carlucci, Maria Dall'Era, Kenneth Kalunian, Chaim Putterman, Jennifer Anolik, Jennifer L. Barnas, David Wofsy, Diane Kamen, Richard A. Furie, Deepak A. Rao, the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus Network, Chun‐Hao Lee, Derek Fine, Manny Monroy‐Trujillo, Ummara Shah, Mariko Ishimori, Robert M. Clancy, Michael Belmont, Ming Wu, Nicole Bornkamp, Evan Der, Beatrice Goilav, Nicole Jordan, Daniel Schwartz, James Pullman, David Wofsy, Dawn Smilek, Patti Tosta, Matthias Kretzler, Celine C. Berthier, E. Steve Woodle, Dave Hildeman, Michael Brenner, Michelle Petri, Joel M. Guthridge, Jill Buyon, Judith A. James   +48 more
wiley   +1 more source

Clinical Presentation, Tumor Characteristics, and Management of Intradiverticular Transitional Cell Carcinoma of the Urinary Bladder: A Systematic Review. [PDF]

Cureus
Aijaz P, Farooqi Baloch K, Faiz H, Durvesh AK, Tirmizi SJ, Khan M, Sohail H, Khalid S, Niazi MA, Kamran A.   +9 more
europepmc   +1 more source

Survey of Mast Cell Density in Transitional Cell Carcinoma. [PDF]

Iran J Pathol, 2021
Moradi Tabriz H, Obohat M, Vahedifard F, Eftekharjavadi A.   +3 more
europepmc   +1 more source